IGM Biosciences, Inc.
MULTIMERIC GITR BINDING MOLECULES AND USES THEREOF

Last updated:

Abstract:

This disclosure provides dimeric, pentameric, and hexameric GITR agonist binding molecules and methods of using such binding molecules to induce anti-tumor immunity.

Status:
Application
Type:

Utility

Filling date:

24 Feb 2022

Issue date:

9 Jun 2022